Primary Site >> Liver Cancer
Gene >> IDO1
| 1. | |||||||||||
| Journal: | Oncotarget. 2016 Mar 22;7(12):14781-90. | ||||||||||
| Title: | Tumoral indoleamine 2, 3-dioxygenase 1 is regulated by monocytes and T lymphocytes collaboration in hepatocellular carcinoma. | ||||||||||
| Author: | Zhao, Qiyi|Wang, Pei-Pei|Huang, Zhan-Lian|Peng, Liang|Lin, Chaoshuang|Gao, Zhiliang|Su, Shicheng | ||||||||||
| PMID: | 26895379 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Res. 2017 Aug 1;77(15):4065-4077. | ||||||||||
| Title: | Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression. | ||||||||||
| Author: | Wang, Li-Ting|Chiou, Shyh-Shin|Chai, Chee-Yin|Hsi, Edward|Yokoyama, Kazunari K|Wang, Shen-Nien|Huang, Shau-Ku|Hsu, Shih-Hsien | ||||||||||
| PMID: | 28625979 | ||||||||||
| 3. | |||||||||||
| Journal: | Sci Rep. 2017 Jul 12;7(1):5170. | ||||||||||
| Title: | Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment. | ||||||||||
| Author: | Chen, Aiping|Zhang, Yonghui|Meng, Gang|Jiang, Dengxu|Zhang, Hailin|Zheng, Meihong|Xia, Mao|Jiang, Aiqin|Wu, Junhua|Beltinger, Christian|Wei, Jiwu | ||||||||||
| PMID: | 28701757 | ||||||||||
| 4. | |||||||||||
| Journal: | Biochem J. 2017 Sep 28;474(20):3391-3402. | ||||||||||
| Title: | Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy. | ||||||||||
| Author: | Ogura, Jiro|Miyauchi, Seiji|Shimono, Kazumi|Yang, Shengping|Gonchigar, Sathisha|Ganapathy, Vadivel|Bhutia, Yangzom D | ||||||||||
| PMID: | 28963435 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncol Lett. 2017 Nov;14(5):5497-5504. | ||||||||||
| Title: | Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis. | ||||||||||
| Author: | Asghar, Kashif|Brain, John|Palmer, Jeremy M|Douglass, Stephen|Naemi, Fatmah M A|O'Boyle, Graeme|Kirby, John|Ali, Simi | ||||||||||
| PMID: | 29113177 | ||||||||||
| 6. | |||||||||||
| Journal: | Cancer Immunol Immunother. 2018 Aug;67(8):1305-1315. | ||||||||||
| Title: | Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma. | ||||||||||
| Author: | Brown, Zachary J|Yu, Su Jong|Heinrich, Bernd|Ma, Chi|Fu, Qiong|Sandhu, Milan|Agdashian, David|Zhang, Qianfei|Korangy, Firouzeh|Greten, Tim F | ||||||||||
| PMID: | 29959458 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Sci. 2018 Sep 27. | ||||||||||
| Title: | Mechanism and prognostic value of indoleamine 2,3-dioxygenase 1 expressed in hepatocellular carcinoma. | ||||||||||
| Author: | Li, Shaolong|Han, Xue|Lyu, Ning|Xie, Qiankun|Deng, Haijing|Mu, Luwen|Pan, Tao|Huang, Xin|Wang, Xia|Shi, Yuanyuan|Zhao, Ming | ||||||||||
| PMID: | 30264546 | ||||||||||